| | Presentation | Webcast |
| March 26, 2024Live-streamed R&D update regarding Paccal Vet | | |
| February 26, 2024Presentation - Vivesto - Fokuserat och slimmat för en nystart | | |
| November 17, 2023Presentation - Vivesto - Paccal Vet redo för nästa steg | | |
| October 26, 2023Interview Erik Penser Bank | | |
| August 24, 2023Presentation - EPB Bolagsdag | | |
| May 25, 2023Presentation Erik Penser Bank | | |
| May 5, 2022Anglonordic Life Science Conference | | |
| March 14, 2022Oasmia Pharmaceutical – Aktiedagen Stockholm | | |
| January 19, 2022Rights Issue Presentation at Erik Penser Bank | | |
| December 2, 2021Presentation at Stora Aktiedagen Stockholm | | |
| December 2, 2021Oasmia - Presentation Erik Penser Bank | | |
| October 21, 2021Interview Erik Penser Bank | | |
| September 29, 2021Naventus LifeScience Summit | | |
| September 7, 2021Presentation at Aktiedagen Stockholm | | |
| June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical | | |
| April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting | | |
| March 21, 2021BioEurope Spring, Virtual | | |
| March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual | | |
| March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil | | |
| January 19, 2021SEB Digital Healthcare Seminar Presentation | | |
| December 3, 2020Oasmia’s Partner Elevar Provides an Update on Apealea Development Plans in Ovarian Cancer | | |
| November 11, 2020Investival Showcase 11-16 November 2020, Virtual Conference | | |
| October 29, 2020BIO-Europe®, Virtual Conference | | |
| October 7, 2020Oasmia Erik Penser Cancer Day Presentation | | |
| September 24, 2020Oasmia Erik Penser Investor Event Presentation | | |
| September 21, 2020Presentation at Sachs Biotech in Europe Forum | | |
| September 15, 2020Aktiedagen Digitalt | | |
| July 30, 2020Analysguiden: Interview with Oasmia | | |
| June 10, 2020Company Presentation Aktiespararna | | |
| June 3, 2020Avanza Börsdag | | |
| May 13, 2020Strategic Review Presentation | | |
| March 25, 2020Elevar deal | | |
| February 14, 2020Oasmia appoints new CEO | | |
| April 28, 2024Swiss Nordic Bio | | |
